A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

Clinical trial NCT06240728 · RECRUITING

Trial details

NCT number: NCT06240728
Sponsor: NextPoint Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm

Start date: 2024-01-22
Primary completion: 2027-08-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.